Genetic analysis of B cell antigen receptor signaling

Annual Review of Immunology

Volumn 17, Issue , 1999, Pages 555-592

  Kurosaki, Tomohiro ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

BCR; BLNK; Btk; Calcium signal; PI 3K; PLC 2; Signal transduction; Syk

Indexed keywords

B LYMPHOCYTE ANTIGEN; CALCIUM; CELL SURFACE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; B LYMPHOCYTE; CELL FATE; CELL PROLIFERATION; CELL SURVIVAL; CLONAL ANERGY; ENZYME REGULATION; GENETIC ANALYSIS; KNOCKOUT MOUSE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; GTP-BINDING PROTEINS; HUMANS; LIPID METABOLISM; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION;

EID: 0033010661     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.17.1.555     Document Type: Review

References (182)

1. Burnet FM. 1959. The Clonal Selection Theory of Acquired Immunity. Cambridge, UK: Cambridge Univ. Press
2. Talmage DW. 1959. Clonal selection theory. Science 129:1643-48
3. Rajewsky K. 1996. Clonal selection and learning in the antibody system. Nature 381:751-58
4. Kitamura D, Roes J, Kuhn R, Rajewsky K. 1991. A B cell deficient mouse by targeted disruption of the membrane exons of the immunoglobulin μ chain gene. Nature 350:423-26
5. Kitamura D, Rajewsky K. 1992. Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion. Nature 356:154-56
6. Kitamura D, Kudo A, Schaal S, Muller W, Melchers F, Rajewsky K. 1992. A critical role of lambda 5 protein in B cell development. Cell 69:823-31
7. Rolink A, Karasuyama H, Grawunder U, Haasner D, Kudo A, Melchers F. 1993. B cell development in mice with a defective lambda 5 gene. Eur. J. Immunol. 23:1284-88
8. Reth M. 1989. Antigen receptor tail clue. Nature 338:383-84
9. Law DA, Chan VWF, Datta SK, DeFranco AL. 1993. B-cell antigen receptor motifs have redundant signalling capabilities and bind the tyrosine kinases PTK72, Lyn, and Fyn. Curr. Biol. 3:645-57
10. Sanchez M, Misulovin Z, Burkhardt AL, Mahajan S, Costa T, Franke R, Bolen JB, Nussenzweig M. 1993. Signal transduction by immunoglobulin is mediated through Igα and Igβ. J. Exp. Med. 178:1049-55
11. Papavasiliou F, Misulovin Z, Suh H, Nussenzweig MC. 1995. The role of Igβ in precursor B cell transition and allelic excludion. Science 268:408-11
12. Teh Y-M, Neuberger MS. 1997. The immunoglobulin (Ig)α and Igβ cytoplasmic domains are independently sufficient to signal B cell maturation and activation in transgenic mice. J. Exp. Med. 185:1753-58
13. Gong S, Nussenzweig MC. 1996. Regulation of an early developmental checkpoint in the B cell pathway by Igβ. Science 272:411-14
14. Nagata K, Nakamura T, Kitamura F, Kuramochi S, Taki S, Campbell KS, Karasuyama H. 1997. The Igα/Igβ heterodimer on μ-negative pro B cells in competent for transducing signals to induce early B cell differentiation. Immunity 7:559-70
15. Gong S, Sanchez M, Nussenzweig MC. 1996. Counterselection against Dμ is mediated through Igα-Igβ. J. Exp. Med. 184:2079-84
16. Torres RM, Flaswinkel H, Reth M, Rajewsky K. 1996. Aberrant B cell development and immune response in mice with a compromised BCR complex. Science 272:1804-8
17. Lam K-P, Kühn R, Rajewsky K. 1997. In vivo ablation of surface immunogloubulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90:1073-83
18. Hibbs ML, Tarlinton DM, Armes J, Grail D, Hodgson G, Maglitto R, Stacker SA, Dunn AR. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83:301-11
19. Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mon S, Watanabe T, Yamamoto T. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in Lyn-deficient mice. Immunity 3:549-60
20. Chan VWF, Meng F, Soriano P, DeFranco AL, Lowell CA. 1997. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal intiation and down-regulation. Immunity 7:69-81
21. Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA, Goodnow CC. 1998. Polygenic autoimmune traits: Lyn, CD22 and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8:497-508
22. O'keefe TL, Williams GT, Davies SL, Nueberger MS. 1996. Hyperresponsive B cells in CD22-deficient mice. Science 274:798-801
23. Otipoby KL, Andersson KB, Draves KE, Klaus SJ, Farr AG, Kerner JD, Perlmutter RM, Law C-L, Clark EA. 1996. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384:634-37
24. Nitschke L, Carsetti R, Ocker B, Kohler G, Lamers MC. 1997. CD22 is a negative regulator of B cell receptor signaling. Curr. Biol. 7:133-43
25. Sato S, Miller AS, Inaoki M, Bock CB, Jansen PJ, Tang MLK, Tedder TF. 1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 5:551-62
26. Doody GM, Justement LB, Delibrias CC, Matthews RJ, Lin J, Thomas ML, Fearon DT. 1995. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269:242-44
27. Nishizumi H, Horikawa K, Mlinaric-Rascan I, Yamamoto T. 1998. A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals. J. Exp. Med. 187:1343-48
28. Smith KGC, Tarlinton DM, Doody GM, Hibbs ML, Fearon DT. 1998. Inhibition of the B cell by CD22: A requirement for Lyn. J. Exp. Med. 187:807-11
29. Turner M, Mee PJ, Costello PS, Williams O, Price AA, Duddy LP, Furlong MT, Geahlen RL, Tybulewicz VLJ. 1995. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378:298-302
30. Cheng AM, Rowley B, Pao W, Hayday A, Bolen JB, Pawson T. 1995. Syk tyrosine kinase required for mouse viability and B-cell development. Nature 378:303-6
31. Turner M, Gulbranson-Judge A, Quinn ME, Walters AE, MacLennan ICM, Tybulewicz VLJ. 1997. Syk tyrosine kinases is required for the positive selection of immature B cells into the recirculating B cell pool. J. Exp. Med. 186:2013-21
32. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037-47
33. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RS, Kuhagawa H, Mohandas T, Quan S, Belmont JW, Cooper MD, Conley ME, Witte ON. 1993. Deficient expression of a B cell cytoplasinic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:279-90
34. Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F, Hammarstrom L, Kinnon C, Levinsky R, Bobrow M, Smith CIE, Bentley DR. 1993. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361:226-33
35. Rawlings DJ, Saffran DC, Tsukada S, Largaespada DA, Grimaldi JC, Cohen RN, Mohr JF, Bazan M, Howard M, Copeland NG, Jenkins NA, Witte ON. 1993. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261:358-61
36. Rawlings DJ, Witte ON. 1994. Bruton's tyrosine kinase is a key regulator in B-cell development. Immunol. Rev. 138:105-19
37. Smith CI, Islam KB, Vorechovsky I, Olerup O, Wallin E, Rabbani H, Baskin B, Hammarstrom L. 1994. X-linked agammaglobulinemia and other immunoglobulin deficiencies. Immunol. Rev. 138:159-83
38. Kerner JD, Appleby MW, Mohr S, Chien DJ, Rawlings DJ, Maliszewski CR, Witte ON, Perlmutter RM. 1995. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 3:301-12
39. Khan WN, Alt FW, Gerstein RM, Malynn BA, Larsson I, Rathbun G, Davidson L, Müller S, Kantor AB, Herzenberg LA, Rosen FS, Sideras P. 1995. Defective B cell development and function in Btk-deficient mice. Immunity 3:283-99
40. Hendriks RW, de Bruijn MFTR, Mass A, Dingjan GM, Karis A, Grosveld F. 1996. Inactivation of BTK by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage. EMBO J. 15:4862-72
41. + thymocytes, and B cell maturation. J. Exp. Med. 183:1707-18
42. Kishihara K, Penninger J, Wallace VA, Kundig TM, Kawai K, Ohashi PS, Thomas ML, Furlonger C, Paige CJ, Mak TW. 1993. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell 74:143-56
43. Benatar T, Carsetti R, Furlonger C, Kamalia N, Mak T, Paige CJ. 1996. Immunoglobulin-mediated signal transduction in B cells from CD45-deficient mice. J. Exp. Med. 183:329-34
44. Cyster JG, Healy JI, Kishihara K, Mak TW, Thomas ML, Goodnow CC. 1996. Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature 381:325-28
45. Bignon JS, Siminovitch KA. 1994. Identification of PTP1C mutation as a genetic defect in motheaten and viable motheaten mice: a step toward defining the roles of protein tyrosine phosphtatases in the regulation of hemopoietic cell differentiation and function. Clin. Immunol. Immunopathol. 73:168-79
46. Shults LD, Sidman CL. 1987. Genetically determined murine models of immunodeficiency. Annu. Rev. Immunol. 5:367-403
47. Tsui FWL, Tsui HW. 1994. Molecular basis of the motheaten phenotype. Immunol. Rev. 136:185-206
48. Cyster JG, Goodnow CC. 1995. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2:13-24
49. - deficient mice. J. Exp. Med. 186:581-88
50. Pawson T, Scott JD. 1997. Signaling through scaffold, anchoring, and adaptor proteins. Science 278:2075-80
51. Dell' Acqua ML, Faux MC, Thorburn J, Thoburn A, Scott JD. 1998. Membrane-targeting sequences on AKAP79 bind phosphatidylinositol-4,5-bisphosphate. EMBO J. 17:2246-60
52. Xavier R, Brennan T, Li Q, McCormack C, Seed B. 1998. Membrane compartmentation is required for efficient T cell activation. Immunity 8:723-32
53. Saouaf SJ, Mahajan S, Rowley RB, Kut SA, Fargnoli J, Burkhardt AL, Tsukada S, Witte ON, Bolen JB. 1994. Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. Proc. Natl. Acad. Sci. USA 91:9524-28
54. tyn domains associate with nonphosphorylated and phosphorylated Ig-α. Proc. Natl. Acad. Sci. USA 91:4268-72
55. Kabouridis PS, Magee AI, Ley SC. 1997. S-acylation of LCK protein tyrosine kinase is essential for its signalling function in T lymphocytes. EMBO J. 16:4983-98
56. + mobilization through distinct pathways. EMBO J. 13:1341-49
57. Takata M, Kurosaki T. 1996. A role for Bruton's tyrosine kinase in BCR-mediated activation of phospholipase C-γ 2. J. Exp. Med. 184:31-40
58. Cooper JA, Howell B. 1993. The when and how of Src regulation. Cell. 73:1051-54
59. Yanagi S, Sugawara M, Kurosaki M, Sabe H, Yamamura H, Kurosaki T. 1996. CD45 modulates phosphorylation of both autophosphorylation and negative regulatory tyrosine of Lyn in B cells. J. Biol. Chem. 271:30487-92
60. Pao LI, Cambier JC. 1997. Syk, but not Lyn, recruitment to B cell antigen receptor and activation following stimulation of CD45 B cells. J. Immunol. 158:2663-69
61. Hata A, Sabe H, Kurosaki T, Takata M, Hanafusa H. 1994. Functional analysis of Csk in signal transduction through the B-cell antigen receptor. Mol. Cell. Biol. 14:7306-13
62. Pao LI, Bedzyk WD, Persin C, Cambier JC. 1997. Molecular targets of CD45 in B cell antigen receptor signal transduction, J. Immunol 158:1116-24
63. Justement LB, Campbell KS, Chien NC, Cambier JC. 1991. Regulation of B cell antigen receptor signal transduction and phosphorylation by CD45. Science 252:1839-42
64. Ogimoto M, Katagiri T, Mashima K, Hasegawa K, Mizuno K, Yakura H. 1994. Negative regulation of apoptotic death in immature B cells by CD45. Int. Immunol. 6:647-54
65. Xu W, Harrison SC, Eck M. 1997. Three-dimensional structure of the tyrosine kinase c-Src. Nature 385:595-602
66. Sicheri F, Moarefi I, Kuriyan J. 1997. Crystal structure of the Src family tyrosine kinase Hck, Nature 385:602-9
67. Weiss A, Littman DR. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76:263-74
68. Kolanus W, Romeo C, Seed B. 1993. T cell activation by clustered tyrosine kinases. Cell 74:171-83
69. Chu DH, Spits H, Peyron J-F, Rowley RB, Bolen JB, Weiss A. 1996. The syk protein tyrosine kinase can function independently of CD45 or Lck in T cell antigen receptor signaling. EMBO J. 15:6251-61
70. Latour S, Fournel M, Veillette A. 1997. Regulation of T-cell antigen receptor signalling by Syk tyrosine protein kinase. Mol. Cell. Biol. 17:4434-11
71. Hutchcroft JE, Harrison ML, Geablen RL. 1992. Association of the 72-kDa protein-tyrosine kinase PTK72 with the B cell antigen receptor. J. Biol. Chem. 267:8613-19
72. Kurosaki T, Johnson SA, Pao L, Sada K, Yamamura H, Cambier JC. 1995. Role of the Syk autophosphorylation site and SH2 domains in B cell receptor signaling. J. Exp. Med. 182:1815-23
73. Rowley RB, Burkhardt AL, Chao HG, Matsueda GR, Bolen JB. 1995. Syk protein-tyrosine kinase is regulated by tyrosine-phosphorylated Igα/Igβ immunoreceptor tyrosine activation motif binding and autophosphorylation. J. Biol. Chem. 270:11590-94
74. Hatada MH, Lu X, Laird ER, Green J, Morgenstern JP, Lou M, Marr CS, Phillips TB, Kam MK, Theriault K, Zoller MJ, Karas JL. 1995. Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature 377:32-38
75. Latour S, Zhang J, Siraganian RP, Veillette A. 1998. A unique insert in the linker domain of Syk is necessary for its function in immunoreceptor signalling. EMBO J. 17:2584-95
76. Kurosaki T, Takata M, Yamanashi Y, Inazu T, Taniguchi T, Yamamoto T, Yamamura H. 1994. Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling. J. Exp. Med. 179:1725-29
77. Keshvara LM, Isaacson C, Harrison L, Geahlen RL. 1997. Syk activation and dissociation from the B-cell antigen receptor is mediated by phosphorylation of tyrosine 130. J. Biol. Chem. 272:10377-81
78. Ota Y, Samelson LE. 1997. The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase. Science 276:418-20
79. Murphy MA, Schnall RG, Venter DJ, Barnett L, Bertoncello I, Thien CBF, Langdon WY, Bowtell DDL. 1998. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-CbI-deficient mice. Mol. Cell. Biol. 18:4872-82
80. Starr R, Willson TA, Viney EM, Murray LJL, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917-21
81. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Maysumoto A, Tanimura S, Ohtsubo M, Miaswa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921-24
82. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924-29
83. Mahajan S, Fargnoli J, Burkhardt AL, Kut SA, Saouaf SJ, Bolen JB. 1995. Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase. Mol. Cell. Biol. 15:5304-11
84. Rawlings DJ, Scharenberg AM, Park H, Wahl MI, Lin S, Kato RM, Fluckiger A-C, Witte ON, Kinet J-P. 1996. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science 271:822-25
85. Kurosaki T, Kurosaki M. 1997. Transphosphorylation of Btk on tyrosine 551 is critical for B cell antigen receptor function. J. Biol. Chem. 272:15595-98
86. Tarakhovsky A. 1997. Xid and Xid-like immunodeficiencies from a signaling point of view. Curr. Opin. Immunol. 9:319-23
87. Park H, Wahl MI, Afar DEH, Turck CW, Rawlings DJ, Tam C, Scharenberg AM, Kinet J-P, Witte ON. 1996. Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity 4:515-25
88. Andreotti AH, Bunnell SC, Feng S, Berg LJ, Schreiber SL. 1997. Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature 385:93-97
89. Matsushita M, Yamadori T, Kato S, Takemoto Y, Inazawa J, Baba Y, Hashimoto S, Sekine S, Arai S, Kunikata T, Kurimoto M, Kishimoto T, Tsukada S. 1998. Identification and characterization of a novel SH3-domain binding protein, Sab, which prefentially associates with Bruton's Tyrosine kinase (Btk). Biochem. Biophys. Res. Comm. 245:337-43
90. Salim K, Bottomley MJ, Querfurth E, Zvelebil MJ, Gout I, Scaife R, Margolis RL, Gigg R, Smith CIE, Driscoll PC, Waterfield MD, Panayotou G. 1996. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J. 15:6241-50
91. Li Z, Wahl MI, Eguinoa A, Stephens LR, Hawkins PT, Witte ON. 1997. Phosphatidylinositol 3-kinase-γ activates Bruton's tyrosine kinase in concert with Src family kinases. Proc. Natl. Acad. Sci. USA 94:13820-25
92. August A, Sadra A, Dupont B, Hanafusa H. 1997. Src-induced activation of inducible T cell kinase (TTK) requires phosphatidylinositol 3-kinase activity and the pleckstrin homology domain of inducible T cell kinase. Proc. Natl. Acad. Sci. USA 94:11227-32
93. Law C-L, Chandran KA, Sidorenko SP, Clark EA. 1996. Phospholipase C-γ 1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk. Mol. Cell. Biol. 16:1305-15
94. Takata M, Homma Y, Kurosaki T. 1995. Requirement of phospholipase C-γ 2 activation in surface IgM-induced B cell apoptosis. J. Exp. Med. 182:907-14
95. Fu C, Turck C, Kurosaki T, Chan AC. 1998. BLNK: A central linker protein in B cell activation. Immunity 9:93-103
96. Wienands J, Schweikert J, Wollscheid B, Jumaa H, Nielsen PJ, Reth M. 1998. SLP-65: A new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation. J. Exp. Med. 188:791-95
97. Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE. 1998. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92:83-92
98. Weber JR, Orstavik S, Torgersen KM, Danbolt NC, Berg SF, Ryan JC, Tasken K, Imboden JB, Vaage JT. 1998. Molecular cloning of the cDNA encoding pp36, a tyrosine-phosphorylated adaptor protein selectively expressed by T cells and natural killer cells. J. Exp. Med. 187:1157-61
99. Peterson EJ, Clements JL, Fang N, Koretzky GA. 1998. Adaptor proteins in lymphocyte antigen-receptor signaling. Curr. Opin. Immunol. 10:337-44
100. 2+ following B-cell receptor activation. EMBO J. 17:1973-85
101. Liu K-Q, Bunnell SC, Gurniak CB, Berg LJ. 1998. T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells. J. Exp. Med. 187:1721-27
102. Falasca M, Logan SK, Lehto VP, Baccante G, Lemmon MA, Schlessinger J. 1998. Activation of phospholipase Cγ by P13-kinase-induced PH domain-mediated membrane targeting. EMBO J. 17:414-22
103. O'Rourke LM, Tooze R, Turner M, Sandoval DM, Carter RH, Tybulewicz VLJ, Fearon DT. 1998. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity 8:635-45
104. Sugawara H, Kurosaki M, Takata M, Kurosaki T. 1997. Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B cell antigen receptor. EMBO J. 16:3078-88
105. 2+ response amplitude and duration. Nature 386:855-58
106. Dolmetsch RE, Xu K, Lewis R. 1998. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392:933-36
107. 2+ spike frequency can optimize gene expression. Nature 392:936-41
108. Jayaraman T, Ondrias K, Ondriasova E, Marks AR. 1996. Regulation of the inositol 1,4,5-trisphosphate receptor by tyrosine phosphorylation. Science 272:1492-94
109. Gold MR, Aehersold R. 1994. Both phosphatidylinositol 3-kinase and phosphatidylinositol 4-kinase products are increased by antigen receptor signaling in B cells. J. Immunol. 152:42-50
110. Beckwith M, Fenton RG, Katona IM, Longo DL. 1996. Phosphatidylinositol-3-kinase activity is required for the anti-Ig-mediated growth inhibition of a human B-lymphoma cell line. Blood 87:202-10
111. Tuveson DA, Carter RH, Soltoff SP, Fearon DT. 1993. CD19 of B cells as a surrogate kinase insert region to bind phophatidylinositol 3-kinase. Science 260:986-89
112. Pleiman CM, Hertz WM, Cambier JC. 1994. Activation of phosphatidylinositol-3′ kinase by Src-family kinase SH3 binding to the p85 subunit. Science 263:1609-12
113. Damen JE, Liu L, Rosten P, Humphries RK, Jefferson AB, Majerus PW, Krystal G. 1996. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase. Proc. Natl Acad. Sci. USA 93:1689-93
114. Helgason CD, Damen JE, Rosten P, Grewal R, Sorensen P, Chappel SM, Borowski A, Jirik F, Krystal G, Humphries RK. 1998. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes & Dev. 12:1610-20
115. Kiener PA, Liboubin MN, Rohrschneider LR, Ledbetter JA, Nadler SG, Diegel ML. 1997. Co-ligation of the Antigen and Fc receptors give rise to the selective modulation of intracellular signaling in B cells. J. Biol. Chem. 272:3838-44
116. Bolland S, Pearse R, Kurosaki T, Ravetch JV. 1998. SHIP Modulates immune receptor responses by regulating membrane association of Btk. Immunity 8:509-16
117. Iritani BM, Forbush KA, Farrar MA, Perlmutter RM. 1997. Control of B cell development by Ras-mediated activation of Raf. EMBO J. 16:7019-31
118. Holsinger LJ, Spencer DM, Austin DJ, Schreiber SL, Crabtree GR. 1995. Signal transduction in T lymphocytes using a conditional allele of Sos. Proc. Natl. Acad. Sci. USA 92:9810-14
119. 2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor. J. Exp. Med. 188:1287-95
120. 2-terminal kinase 1, and p38 mitogen-activated protein kinase activation. J. Exp. Med. 188:1297-306
121. Ingham RJ, Krebs DL, Barbazuk SM, Turck CW, Hirai H, Matsuda M, Gold MR. 1996. B cell antigen receptor signaling induces the formation of complexes containing the Crk adapter proteins. J. Biol. Chem. 271:32306-14
122. Smit L, van der Horst G, Borst J. 1996. Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors. J. Biol. Chem. 271:8564-69
123. McCormick F, Wittinghofer A. 1996. Interactions between Ras proteins and their effectors. Curr. Opin. Biotechnol. 7:449-56
124. Fukazawa T, Reedquist KA, Trub T, Soltoff S, Panchamoorthy G, Druker B, Cantley L, Shoelson SE, Band H. 1995. The SH3 domain-binding T cell tyrosyl phosphoprotein p120. Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase. J. Biol. Chem. 270:19141-50
125. lyn, in the B cell antigen receptor-mediated signaling. J. Exp. Med. 183:675-80
126. Ota Y, Beitz LO, Scharenberg AM, Donovan JA, Kinet J-P, Samelson LE. 1996. Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells. J. Exp. Med. 184:1713-23
127. ras GTPase-activating protein (GAP) and two GAP-associated proteins. J. Immunol. 150:377-86
128. ras and ras-GAP signaling pathway. J. Exp. Med. 178:1765-69
129. Settleman J, Albright CF, Forest LC, Weinberg RA. 1992. Association between GTPase activators for Rho and Ras families. Nature 359:153-54
130. dok: a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myclogcnous leukemia progenitor cells. Cell 88:197-204
131. Yamanashi Y, Baltimore D. 1997. Identification of the Abl-and rasGAP-associated 62 kDa protein as a docking protein Dok. Cell 88:205-11
132. Tarakhovsky A, Turner M, Schaal S, Mee PJ, Duddy LP, Rajewsky K, Tybulewicz VLJ. 1995. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374:467-70
133. Zhang R, Alt FW, Davidzon L, Orkin SH, Swat W. 1995. Defective signalling through the T-and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374:470-73
134. + thymocytes. Nature 374:474-77
135. Fischer K-D, Kong Y-Y, Nishina H, Tedford K, Marengere LEM, Kozieradzki I, Sasaki T, Starr M, Chan G, Gardener S, Nghiem MP, Bouchard D, Barbacid M, Bernstein A, Penninger JM. 1998. Vav is regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr. Biol. 8:554-62
136. Holsinger LJ, Graef IA, Swat W, Chi T, Bautista DM, Davidzon L, Lweis RS, Alt FW, Crabtree GR. 1998. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 8:563-72
137. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR. 1997. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385: 169-72
138. Wu J, Motto DG, Koretzky GA, Weiss A. 1996. Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity 4:593-602
139. Deckert M, Tartare-Deckert S, Couture C, Mustelin T, Altman A. 1996. Functional and physical interactions of Syk-family kinases with the Vav protooncogene product. Immunity 5:591-604
140. Han J, Luby-Phelps K, Das K, Shu X, Xia Y, Mosteller RD, Krishna UM, Falck JR, White MA, Broek D. 1998. Role of substrates and products of PI3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 279:558-60
141. Nonoyama S, Ochs UD. 1998. Characterization of the Wiskott-Aldrich syndrome protein and its role in the disease. Curr. Opin. Immunol. 10:407-12
142. Symons M, Derry JMJ, Karlark B, Jiang S, Lemahieu V, McCormick F, Francke U, Abo A. 1996. Wiskott-Aldrich syndrome protein, a novel effector for the GTPasa CDC42Hs, is implicated in actin polymerization. Cell 84:723-34
143. Schreiber SL, Crabtree GR. 1992. The mechanism of action of cyclosporin A and FK506. Immunol. Today. 13:136-42
144. Choi MSK, Brines RD, Holman MJ, Klaus GGB. 1994. Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 ligand in conjunction with IL-4. Immunity 1:179-87
145. Ventakaraman L, Francis DA, Wang Z, Liu J, Rothstein TL, Sen R. 1994. Cyclosporin-A sensitive induction of NF-AT in murine B cells. Immunity 1:189-96
146. Genestier L, Dearden-Badet MT, Bonnefoy-Berard N, Lizard G, Revillard JP. 1994. Cyclosporin A and FK506 inhibit activation-induced death in the murine WEHI-231 B cell line. Cell Immunol. 155:283-91
147. Graves JD, Draves KE, Craxton A, Saklatvala J, Krebs EG, Clark EA. 1996. Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. Proc. Natl. Acad. Sci. USA 93:13814-18
148. Zhu J, Shibasaki F, Price R, Guillemot J-C, Yano T, Dotsch V, Wagner G, Ferrara P, McKeon F. 1998. Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. Cell 93:851-61
149. Beals CR, Clipstone NA, Ho SN, Crabtree GR. 1997. Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes & Dev. 11:824-34
150. Beals CR, Sheridan CM, Turck CW, Gardner P, Crabtree GR. 1997. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275:1930-33
151. Fukuda T, Kitamura D, Taniuchi I, Maekawa Y, Benhamou LE, Sarthou P, Watanabe T. 1995. Restoration of surface IgM-mediated apoptosis in an anti-IgM-resistant variant of WEHI-231 lymphoma cells by HS1, a protein-tyrosine kinase substrate. Proc. Natl. Acad. Sci. USA 92:7302-6
152. Yamanashi Y, FukudaT, Nishizumi H, Inazu T, Higashi K, Kitamura D, Ishida T, Yamamura H, Watanabe T, Yamamoto T. 1997. Role of tyrosine phosphorylation of HS1 in B cell antigen receptor-mediated apoptosis. J. Exp. Med. 185:1387-92
153. Leitges M, Schmedt C, Guinamard R, Davoust J, Schaal S, Stable S, Tarakhovsky A. 1996. Immunodeficiency in protein kinase Cβ-deficient mice. Science 273:788-91
154. Sidorenko SP, Law C-L, Klaus SJ, Chandran KA, Takata M, Kurosaki T, Clark EA. 1996. Protein kinase Cμ (PKCμ) associates with the B cell antigen receptor complex and regulates lymphocyte signaling. Immunity 5:353-63
155. Franke TF, Kaplan DR, Cantley LC. 1997. P13K: downstream AKTion blocks apoptosis. Cell 88:435-37
156. Hammings BA. 1997. Akt signaling: linking membrane events to life and death decisions. Science 275:028-30
157. Stokoe D, Stephens LR, Copeland T, Gaffney PRJ, Reese CB, Painter GF, Holmes AB, McCormic F, Hawkins PT. 1997. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277:567-70
158. Cross DAE, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-89
159. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-41
160. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G. 1997. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687-89
161. Cohen P. 1997. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol. 7:353-61
162. Jacinto E, Werlen G, Karin M. 1998. Cooperation between Syk and Rac I leads to synergistic JNK activation in T lymphocytes. Immunity 8:31-41
163. Werlen G, Jacinto E, Xia Y, Karin M, 1998. Calcineurin preferentially synergizes with PKC-θ to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 17:3101-11
164. Ono M, Holland S, Tempst P, Ravetch JV. 1996. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fcγ RIIB. Nature 383:263-66
165. Ono M, Okada H, Holland S, Yanagi S, Kurosaki T, Ravetch JV. 1997. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 90:293-301
166. 3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory. EMBO J. 17: 1961-72
167. O'Rourke L, Tooze R, Fearon DT. 1997. Co-receptors of B lymphocytes. Curr. Opin. Immunol. 9:324-29
168. Blery M, Kubagawa H, Chen C-C, Vely F, Cooper MD, Vivier E. 1998. The paired lg-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc. Natl. Acad. Sci. USA 95:2446-51
169. Maeda A, Kurosaki M, Ono M, Takai T, Kurosaki T. 1998. Requirement of tyrosine phosphatase SHP-1 and SHP-2 for PIR-B-mediated inhibitory signal. J. Exp. Med. 187:1335-60
170. Yellen AJ, Glenn W, Sukhatme VP, Cao SM, Monroe JG. 1991. Signaling through surface IgM in tolerance-susceptible immature murine B lymphocytes. Developmentally regulated difference in trans-membrane signaling in splenic B cells from adult and neonatal mice. J. Immunol. 146:1446-54
171. Seyfert VL, McMohan SB, Glenn WD, Yellen AJ, Sukhatme VP, Cao X, Monroe JG. 1990. Methylation of an immediate-early inducible gene as a mechanism for B cell tolerance induction. Science 250:797-800
172. Russell DM, Dembic Z, Morahan G, Miller JFAP, Bürki K, Nemazee D. 1991. Peripheral deletion of self-reactive B cells. Nature 354:308-11
173. Hartley SB, Crosbie J, Brink R, Kantor AA, Basten A, Goodnow CC. 1991. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens, Nature 353:765-68
174. Okamoto M, Murakami M, Shimizu A, Ozaki S, Tsubata K, Kumagai S, Honjo T. 1992. A transgenic model of autoimmune hemolytic anemia. J. Exp. Med. 175:71-79
175. Chen C, Nagy Z, Radic M, Hardy R, Huzar D, Camper SA, Weight M. 1995. The site and stage of anti-DNA B-cell deletion. Nature 373:252-55
176. Melamed D, Benschop RJ, Gambier JC, Nemazec D. 1998. Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. Cell 92:173-82
177. Healy JI, Dolmetsch RE, Timmerman LA, Cyster JG, Thomas ML, Crahtree GR, Lewis RS, Goodnow CC. 1997. Different nuclear signals are activated by the B cell receptor during positive versus nagative signaling. Immunity 6:419-28
178. Cooke MP, W. HA, Shokat KM, Zeng Y, Finkelman FD, Linsely PS, Howard M, Goodnow CC. 1994. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J. Exp. Med. 179:425-38
179. Wienands J, Larbolette O, Reth M. 1996. Evidence for a preformed transducer complex organized by the B cell antigen receptor. Proc. Natl. Acad. Sci. USA 93:7865-70
180. Scharenberg AM, Kinet J-P. 1998. PtdIns-3,4,5-P3: a regulatory nexus between tirosine kinases and sustained calcium signals. Cell 94:5-8
181. 2+ oscillatory response. J. Immunol. (in press)
182. Maeda A, Scharenberg AM, Tsukada S, Bolen JB, Kinet J-P, Kurosaki T. 1999. Paired Immunoglobulin-like receptor B (PTR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1. Oncogene (in press)